BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 12809832)

  • 1. High prevalence of fatigue in quiescent inflammatory bowel disease is not related to adrenocortical insufficiency.
    Minderhoud IM; Oldenburg B; van Dam PS; van Berge Henegouwen GP
    Am J Gastroenterol; 2003 May; 98(5):1088-93. PubMed ID: 12809832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatigue in patients with primary sclerosing cholangitis.
    Björnsson E; Simren M; Olsson R; Chapman RW
    Scand J Gastroenterol; 2004 Oct; 39(10):961-8. PubMed ID: 15513335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of sleep disturbances in inflammatory bowel disease.
    Ranjbaran Z; Keefer L; Farhadi A; Stepanski E; Sedghi S; Keshavarzian A
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1748-53. PubMed ID: 17914945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatigue in out-patients with inflammatory bowel disease is common and multifactorial.
    Bager P; Befrits R; Wikman O; Lindgren S; Moum B; Hjortswang H; Hjollund NH; Dahlerup JF
    Aliment Pharmacol Ther; 2012 Jan; 35(1):133-41. PubMed ID: 22059387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing health-related quality of life in patients with inflammatory bowel disease in Zhejiang, China.
    Zhou Y; Ren W; Irvine EJ; Yang D
    J Clin Nurs; 2010 Jan; 19(1-2):79-88. PubMed ID: 20500246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease-related worries and concerns: a study on out-patients with inflammatory bowel disease.
    Moser G; Tillinger W; Sachs G; Genser D; Maier-Dobersberger T; Spiess K; Wyatt J; Vogelsang H; Lochs H; Gangl A
    Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):853-8. PubMed ID: 8574717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Osteoporosis in inflammatory bowel disease - results of a survey among members of the German Crohn's and Ulcerative Colitis Association].
    von Tirpitz C; Steder-Neukamm U; Glas K; Sander S; Ring C; Klaus J; Reinshagen M
    Z Gastroenterol; 2003 Dec; 41(12):1145-50. PubMed ID: 14661123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease.
    Summers RW; Elliott DE; Qadir K; Urban JF; Thompson R; Weinstock JV
    Am J Gastroenterol; 2003 Sep; 98(9):2034-41. PubMed ID: 14499784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysplasia and cancer in inflammatory bowel disease 10 years after diagnosis: results of a population-based European collaborative follow-up study.
    Katsanos KH; Vermeire S; Christodoulou DK; Riis L; Wolters F; Odes S; Freitas J; Hoie O; Beltrami M; Fornaciari G; Clofent J; Bodini P; Vatn M; Nunes PB; Moum B; Munkholm P; Limonard C; Stockbrugger R; Rutgeerts P; Tsianos EV;
    Digestion; 2007; 75(2-3):113-21. PubMed ID: 17598963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient subjective assessment of drug side effects in inflammatory bowel disease.
    Cross RK; Lapshin O; Finkelstein J
    J Clin Gastroenterol; 2008 Mar; 42(3):244-51. PubMed ID: 18223502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of thrombin-activatable fibrinolysis inhibitor (TAFI) plasma levels in inflammatory bowel diseases.
    Saibeni S; Bottasso B; Spina L; Bajetta M; Danese S; Gasbarrini A; de Franchis R; Vecchi M
    Am J Gastroenterol; 2004 Oct; 99(10):1966-70. PubMed ID: 15447757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperhomocysteinemia in inflammatory bowel disease patients without past intestinal resections: correlations with cobalamin, pyridoxine, folate concentrations, acute phase reactants, disease activity, and prior thromboembolic complications.
    Erzin Y; Uzun H; Celik AF; Aydin S; Dirican A; Uzunismail H
    J Clin Gastroenterol; 2008; 42(5):481-6. PubMed ID: 18344891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in fatigue over 2 years are associated with activity of inflammatory bowel disease and psychological factors.
    Graff LA; Clara I; Walker JR; Lix L; Carr R; Miller N; Rogala L; Bernstein CN
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1140-6. PubMed ID: 23602816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of autonomic dysfunction on inflammatory bowel disease.
    Ananthakrishnan AN; Issa M; Barboi A; Jaradeh S; Zadvornova Y; Skaros S; Johnson K; Otterson MF; Binion DG
    J Clin Gastroenterol; 2010 Apr; 44(4):272-9. PubMed ID: 19727003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
    Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
    Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An initial report of sleep disturbance in inactive inflammatory bowel disease.
    Keefer L; Stepanski EJ; Ranjbaran Z; Benson LM; Keshavarzian A
    J Clin Sleep Med; 2006 Oct; 2(4):409-16. PubMed ID: 17557469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-inflammatory joint pain in patients with inflammatory bowel disease is prevalent and has a significant impact on health related quality of life.
    Palm Ø; Bernklev T; Moum B; Gran JT
    J Rheumatol; 2005 Sep; 32(9):1755-9. PubMed ID: 16142874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the functional assessment of chronic illness therapy-fatigue (FACIT-F) in patients with inflammatory bowel disease.
    Tinsley A; Macklin EA; Korzenik JR; Sands BE
    Aliment Pharmacol Ther; 2011 Dec; 34(11-12):1328-36. PubMed ID: 21999576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life in inflammatory bowel disease.
    Martin A; Leone L; Fries W; Naccarato R
    Ital J Gastroenterol; 1995; 27(8):450-4. PubMed ID: 8775474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for abnormal liver function tests in patients with ileal pouch-anal anastomosis for underlying inflammatory bowel disease.
    Navaneethan U; Remzi FH; Nutter B; Fazio VW; Shen B
    Am J Gastroenterol; 2009 Oct; 104(10):2467-75. PubMed ID: 19550410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.